The Current Ratio as of November 2024 (TTM) for Biostage, Inc. (BSTG) is 1.79

According to Biostage, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.79. This represents a change of -13.01% compared to the average of 2.06 of the last 4 quarters.

Biostage, Inc. (BSTG) Historical Current Ratio (quarterly & annually)

How has BSTG Current Ratio performed in the past?

The mean historical Current Ratio of Biostage, Inc. over the last ten years is 3.31. The current 1.79 Current Ratio has changed 5.31% with respect to the historical average. Over the past ten years (40 quarters), BSTG's Current Ratio was at its highest in in the December 2013 quarter at 29.27. The Current Ratio was at its lowest in in the December 2021 quarter at 0.40.

Biostage, Inc. (BSTG) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Biostage, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Biostage, Inc. (BSTG) Average Current Ratio

How has BSTG Current Ratio performed in the past?

The current Current Ratio of Biostage, Inc. (BSTG) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Biostage, Inc. (BSTG) Current Ratio vs. Peers

How is BSTG’s Current Ratio compared to its peers?

Biostage, Inc.’s Current Ratio is greater than Biotron Limited (0.58), greater than Bioasis Technologies Inc. (0), less than Covalon Technologies Ltd. (5.24), greater than Mosaic ImmunoEngineering Inc. (0.06), less than Ceapro Inc. (7.10), greater than Cellectis S.A. (1.78), less than SanBio Company Limited (5.30), less than Alterity Therapeutics Limited (3.54), less than Amplia Therapeutics Limited (1.98), greater than Adynxx, Inc. (0), less than Sosei Group Corporation (4.11), less than Antibe Therapeutics Inc. (10.06), greater than Awakn Life Sciences Corp. (0.35), greater than Tryp Therapeutics Inc. (0.08), greater than America Great Health (0.08), greater than Resverlogix Corp. (0.11), less than Small Pharma Inc. (5.77),

Build a custom stock screener for Biostage, Inc. (BSTG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biostage, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biostage, Inc. (BSTG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biostage, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.